Establishment Labs Execs to Present at TD Cowen Health Care Conference
Event summary
- Establishment Labs (NASDAQ: ESTA) will present at TD Cowen's 46th Annual Health Care Conference on March 2, 2026.
- CEO Peter Caldini and CFO Raj Denhoy will participate in a fireside chat at 9:10 a.m. ET.
- Live webcast available via Establishment Labs' investor relations website.
- Company focuses on breast aesthetics and reconstruction with products like Motiva®, Mia Femtech®, and Preservé®.
The big picture
Establishment Labs' participation in TD Cowen's conference underscores its strategic focus on investor engagement amid a competitive landscape in women’s health and wellness. The company's portfolio of minimally invasive solutions positions it as a key player, but scaling innovation while maintaining regulatory compliance remains critical.
What we're watching
- Product Pipeline
- How the progress of GEM® and Zenº™ biosensor pivotal studies will impact investor sentiment.
- Market Expansion
- Whether Establishment Labs can sustain its global reach in over 90 countries amid competitive pressures.
- Regulatory Compliance
- The pace at which the company navigates international regulatory standards for its medical devices.